Showing results (461-470 of 1,201) with videos related to
Sort By:
Pageof 121
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2015
Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trialPascal Vranckx, Marco Valgimigli, Stephan Windecker, et al.American Heart Journal|September 1, 2014
Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trialThomas Pilgrim, Marco Roffi, David Tüller, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 6, 2020
Impact of individual stroke risk on outcome after Amplatzer left atrial appendage closure in patients with atrial fibrillationJonas D Häner, Monika Fürholz, Caroline Kleinecke, et al.The Journal of Invasive Cardiology|March 2, 2018
Short-Term Outcome After Left Main Interventions in Patients Presenting With Acute Coronary SyndromeSlayman Obeid, Nooraldaem Yousif, Andreas Schelldorfer, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 25, 2020
Randomized Comparison of Optical Coherence Tomography Versus Angiography to Guide Bioresorbable Vascular Scaffold Implantation: The OPTICO BVS StudyYasushi Ueki, Kyohei Yamaji, Emanuele Barbato, et al.European Journal of Preventive Cardiology|December 11, 2021
Clinical outcomes and cardiac rehabilitation in underrepresented groups after percutaneous coronary intervention: an observational studyNathalia Gonzalez-Jaramillo, Thimo Marcin, Sophia Matter, et al.The American Journal of Cardiology|May 3, 2011
Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stentsGiovanna Sarno, Lorenz Räber, Yoshinobu Onuma, et al.European Heart Journal|March 27, 2012
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trialsGiulio G Stefanini, Robert A Byrne, Patrick W Serruys, et al.European Heart Journal. Acute Cardiovascular Care|September 25, 2013
Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011Dragana Radovanovic, Bramajee K Nallamothu, Burkhardt Seifert, et al.American Journal of Preventive Cardiology|April 15, 2025
Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States populationRahul Aggarwal, Deepak L Bhatt, Marc P Bonaca, et al.Pageof 121